Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS- related Kaposi's sarcoma after failure of standard chemotherapy

Journal of Clinical Oncology

Volumn 15, Issue 2, 1997, Pages 653-659

  Northfelt, D W ^a   Dezube, B J ^a   Thommes, J A ^a   Levine, R ^a   Von Roenn, J H ^a   Dosik, G M ^a   Rios, A ^a   Krown, S E ^a   DuMond, C ^a   Mamelok, R D ^a  

^a ALZA CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; DOXORUBICIN; LIPOSOME; VINCRISTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALOPECIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KAPOSI SARCOMA; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT OUTCOME; VOMITING;

EID: 0031036426     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.2.653     Document Type: Article

References (21)

1. Beral V, Peterman TA, Berkelman RL, et al.: Kaposi's sarcoma among persons with AIDS: A sexually transmitted infection. Lancet 1:123-128, 1990
2. Northfelt DW: AIDS-related Kaposi's sarcoma: Still a problem, still an opportunity. J Clin Oncol 12:1109-1110, 1994
3. Peters BS, Beck EJ, Coleman DG, et al.: Changing disease patterns in patients with AIDS in a referral centre in the United Kingdom: The changing face of AIDS. Br J Med 302:203-207, 1991
4. Selik RM, Chu SY, Ward JW: Trends in infectious disease and cancers among persons dying of HIV infection in the United States from 1987 to 1992. Ann Intern Med 123:933-936, 1995
5. Northfelt DW: Treatment of Kaposi's sarcoma: Current guidelines and future perspectives. Drugs 48:569-582, 1994
6. Gill PS, Rarick M, McCutchan JA, et al.: Systemic treatment of AIDS-related Kaposi's sarcoma: Results of a randomized trial. Am J Med 90:427-433, 1991
7. Gabizon A: Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. Cancer Res 52:891-896, 1992
8. Uziely B, Jeffers S, Isacson R, et al.: Liposomal doxorubicin: Antitumor activity and unique toxicities during two complementary phase I studies. J Clin Oncol 13:1777-1785, 1995
9. Gabizon A, Barenholz Y, Bialer M: Prolongation of circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: Pharmacokinetic studies in rodents and dogs. Pharmaceut Res 10:703-708, 1993
10. Northfelt DW, Martin FJ, Working P, et al.: Pharmacokinetics, tumor localization, and safety of peglyated-liposomal doxorubicin in patients with AIDS-related Kaposi's sarcoma. J Clin Pharmacol 36:55-63, 1996
11. Huang SK, Mahew E, Gilani S: Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma. Cancer Res 52:6774-6781, 1992
12. Vaage J, Barbera-Guillem E, Abra R, et al.: Tissue distributions and therapeutic effects of intravenous free and liposomal doxorubicin against human prostatic carcinoma xenografts. Cancer 73:1478-1484, 1994
13. Northfelt DW: Stealth liposomal doxorubicin (SLD) delivers more doxorubicin (DOX) to AIDS-Kaposi's sarcoma (AIDS-KS) lesions than to normal skin. Proc Am Soc Clin Oncol 13:51, 1994 (abstr)
14. Krown SE, Metroka C, Wernz JC: Kaposi's sarcoma in the acquired immunodeficiency syndrome: A proposal for uniform evaluation, response, and staging criteria. J Clin Oncol 7:1201-1207, 1989
15. Saville MW, Lietzman J, Pluda JM, et al.: Treatment of HIV-associated Kaposi's sarcoma with paclitaxel. Lancet 346:26-28, 1995
16. Fischl MA, Krown SE, O'Boyle KP, et al.: Weekly doxorubicin in the treatment of patients with AIDS-related Kaposi's sarcoma. J AIDS 6:259-264, 1993
17. Gill P, Rarick M, Bernstein-Singer M, et al.: Treatment of advanced Kaposi's sarcoma using a combination of bleomycin and vincristine. Am J Clin Oncol 13:315-319, 1990
18. Rarick MU, Gill PS, Montgomery T, Bernstein-Singer M, Jones B, Levine AM: Treatment of epidemic Kaposi's sarcoma with combination chemotherapy (vincristine and bleomycin) and zidovudine. Ann Oncol 1:147-149, 1990
19. Laubenstein LJ, Krigel RL, Odajnyk CM, et al.: Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastine. J Clin Oncol 2:1115-1120, 1984
20. Working PK, Newman MS, Carter JL, Kerl RE, Kiorpes AL: Comparative target organ toxicity of free and liposome-encapsulated doxorubicin in rats. Toxicologist 14:217, 1994
21. Newman MS, Yarrington J, Sullivan T, Working PK: Comparative cardiotoxicity after repeated DOX-SL administration in rabbits. Toxicologist 15:70, 1994